As countries around the world race to develop a vaccine for SARS-CoV-2, the virus responsible for COVID-19, researchers are working to understand exactly how it causes the myriad of symptoms that seem to linger long after active viral infection.

As countries around the world race to develop a vaccine for SARS-CoV-2, the virus responsible for COVID-19, researchers are working to understand exactly how it causes the myriad of symptoms that seem to linger long after active viral infection.
The PCSK9 inhibitor lowered LDL cholesterol by 38% vs placebo in HAUSER-RCT, the first randomized controlled trial of one of these agents in the pediatric population.
Medscape Medical News
Researchers from Sechenov University together with Russian and Iranian colleagues described currently known approaches to the treatment of SARS-CoV-2 infection.
A new study shows for the first time the utility of this novel approach in persistent AF but experts caution its early days ablating beyond the pulmonary vein and more safety data are needed.
Medscape Medical News
The U.S. Food and Drug Administration announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on CutOct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19.
Incorporating camptothecins into a multivalent, polymer-based prodrug can overcome resistance in high-risk solid tumors and reduce toxicities, researchers found in preclinical experiments.
Reuters Health Information
Over 1,000 children from Northern Ireland, Scotland, England and Wales, known as ‘COVID Warriors’ have had their antibodies measured in the UK-wide trial called ‘Seroprevalence of SARS-Cov-2 infection in healthy children’.
Since the early days of the coronavirus pandemic, it’s been known that older men have a higher risk of getting very sick and dying than older women.
WebMD Health News
Vice President Mike Pence portrayed his boss, President Donald Trump, as a leader who has reached out across the aisle to help during the coronavirus pandemic.
A team of researchers at Children’s Hospital of Philadelphia affiliated with the CHOP Epilepsy Neurogenetics Initiative have combined clinical information with large-scale genomic data to successfully link characteristic presentations of childhood epilepsies with specific genetic variants.